Lucite tombstone marking the acquisition of Catalyst Regulatory Services, which provides regulatory support for biopharmaceutical firms.
(20AMF027)These custom designs highlight deal toys within the healthcare space, but also include vial embedments for drug launches, and commemoratives for FDA approval milestones, therapeutic studies, in-human testing, and other industry landmarks.
Lucite tombstone marking the acquisition of Catalyst Regulatory Services, which provides regulatory support for biopharmaceutical firms.
(20AMF027)Crystal tombstone marking the initial public offering of Japanese medical database company JMDC.
(20ALJ018)Custom financial tombstone recognizing a follow-on offering by Turning Point Therapeutics. Turning Point is a clinical-stage biopharmaceutical company focused on oncology therapies.
(9ALJ524)Lucite deal toy marking an institutional placement by AVITA Medical. The company has developed proprietary technology for skin cell therapy and regeneration.
(20ALJ044)Lucite tombstone commemorating a public offering of stock by Achieve Life Sciences. Achieve is engaged in the development and cytisinicline, a plant-based alkaloid used for smoking cessation and nicotine addiction.
(20AMF022)Custom Lucite tombstone commemorating the acquisition of Quadrants Scientific, a San Diego-based chemical and microbiological testing laboratory.
(20ALJ029)Custom deal toy celebrating an equity raise for Micro-X, a producer of lightweight X-ray products.
(9ALJ593)Deal toys in the healthcare and pharmaceutical space reflect a broad range of financial transactions. These deals involve an array of industry players, including drug companies, hospital chains, medtech firms, manufacturers of medical devices, developers of diagnostic equipment, senior living facilities, pharmacies, and testing laboratories, as well as healthcare-focused funds and venture capital firms.
The transactions themselves include mergers and acquisitions, initial public offerings, bond issues, financings, private placements, and early-stage funding rounds.
But also represented here are transactions more unique to the sector, such as drug licensing, royalty, and commercialization agreements.
The custom designs in these galleries also celebrate non-financial industry achievements and milestones. You will see here, for instance, commemoratives involving submissions and approvals from the Food & Drug Administration (FDA) and European Medicines Agency (EMA), therapeutic studies, joint ventures, successful preclinical and in-human testing stages, and product launches.
These milestones can be commemorated with designs incorporating items unique to the specific event, achievement, or innovation being recognized. These design options include, for example, Lucite embedments of actual drug vials and medical devices.
You’ll also find here commemoratives for a variety of other sector-related events. These include custom awards and gifts honoring speakers and attendees at national and international health summits and medical conferences.
"*" indicates required fields